New ProEZGC Library: Drugs of Abuse (and TMS-derivatives) on the Rxi-5Sil MS
5 Oct 2022Identification and monitoring of drugs of abuse is often associated with forensic science but has well established purpose in medicine and environmental sciences as well. In addition to being heavily intertwined with the law, drugs of abuse can change medical outcomes and diagnoses, and contribute to ecological shifts (especially though water contamination)1–3. Since human creativity knows no bounds, the list of drugs being monitored in various fields is continuously growing. New illicit drugs emerge frequently alongside legal pharmaceuticals and everyday products that may be misused recreationally 4. Consequently, the field of drug analysis can be, in part, exploratory. There is a balance that must be struck between identifying the drugs you know that may be in a sample, and what you may not.
Restek maintains ProEZGC libraries of common drugs of abuse that may exist in samples to help customers effortlessly refine methods in less time. This can be especially helpful for resolving co-elution between known and unknown compounds. Table 1 lists the drugs that are now included in the Rxi-5Sil MS library.
Table 1: Compounds included in the Rxi-5Sil MS Drugs of Abuse library
Amphetamine |
Norcotinine |
THCA-A |
Zolpidem |
Phentermine |
trans-3-Hydroxycotinine |
Δ9-THC |
7-Aminoclonazepam |
Methamphetamine |
Secobarbital |
Nordiazepam |
Clonazepam |
Nicotine |
Diphenhydramine |
Chlordiazepoxide |
JWH-250 |
1S,2R-(+)-Ephedrine |
Zonisamide |
Clobazam |
Estazolam |
Methylephedrine |
Phenobarbital |
XLR-11 |
Alprazolam |
Mephedrone |
Levamisole |
Benzoylecgonine |
HU-211 |
MDA |
Norcocaine |
Temazepam |
Zaleplon |
Anabasine |
MDPV |
Midazolam |
Triazolam |
BZP |
Methaqualone |
Flunitrazepam |
JWH-073 |
Diethylpropion |
m-Hydroxybenzoylecgonine |
7-Aminoflunitrazepam |
α-Hydroxyalprazolam |
Barbital |
Cocaine |
Prazepam |
Zopiclone |
MDMA |
Lisdexamfetamine |
Promethazine 2 |
JWH-018 |
MDEA |
Cocaethylene |
2-Hydroxyethylflurazepam |
Norverapamil |
Butalbital |
Promethazine 1 |
N-Desmethylflunitrazepam |
Droperidol |
Cotinine |
Oxazepam |
Phenazepam |
Zolpidem Phenyl-4-carboxylic acid |
Methylone |
Lorazepam |
7-Aminonitrazepam |
JWH-200 |
Amobarbital |
Diazepam |
α-Hydroxymidazolam |
|
Methylphenidate |
Desalkylflurazepam |
Flurazepam |
|
Pentobarbital |
UR-144 |
Nitrazepam |
The Rxi-5Sil MS is great general-purpose column for analyzing drugs of abuse, but there are some analytes that may require a stationary phase with different selectivity. Since changing columns can be complicated in high-throughput labs, derivatization is a useful technique when dealing with issues of volatility, stability, or inadequate resolution (ex: stereoisomers on an achiral column) 4. Unfortunately, it involves additional chemical reactions which introduce some layers of error and uncertainty. Derivatization reagents can also be harsh on the column phase, reducing column lifetime. Luckily, the Rxi-5sil MS is notably resilient to derivatization reagents. Trimethyl silyl (TMS) derivatization is one of the most common, and widely accepted, derivatization approaches for drugs of abuse 3,5,6. Generally, reagents such as BSTFA, TMSI, or TMCS are added to the sample in a heated, anhydrous, environment, leading to substitution of hydroxyl groups with TMS which improves peaks shapes and analyte resolutions.
Generally, retention time changes when derivatizing, which is why we are proud to introduce a collection of derivatized drugs to our Rxi-5SilMS EZGC library as well (Table 2).
Table 2: Compounds included in the Rxi-5Sil MS Drugs of Abuse (TMS) library
Pregabalin TMS derivative |
Norcocaine TMS derivative |
THCA-A TMS derivative |
Gabapentin TMS derivative |
∆-9-THC TMS derivative |
Paroxetine TMS derivative |
BZP TMS derivative |
(-)-Dihydrocodeine TMS derivative |
Clonazepam TMS derivative |
MDMA TMS derivative |
Dihydromorphine TMS derivative |
(-)-Naloxone TMS derivative |
Ritalinic acid TMS derivative |
Codeine TMS derivative |
Butorphanol TMS derivative |
Norfentanyl TMS derivative |
Norhydrocodone TMS derivative |
11-Nor-9-carboxy-delta-9-THC TMS derivative |
Milnacipran TMS derivative |
Hydromorphone TMS derivative |
Tiagabine TMS derivative |
Phenytoin TMS derivative |
Normorphine TMS derivative |
Nalbuphine TMS derivative |
Pentazocine TMS derivative |
Oxycodone TMS derivative |
LSD TMS derivative |
Benzoylecgonine TMS derivative |
Oxymorphone TMS derivative |
These libraries will be helpful for separating the compounds you know from those you don’t, helping to streamline identification for forensic, medical, and environmental detection.
Is there a compound you wish was in the library? Let us know!
Further reading:
- Tamama, K. Advances in Drugs of Abuse Testing. Clinica Chimica Acta 2021, 514, 40–47. https://doi.org/10.1016/j.cca.2020.12.010.
- Fontes, M. K.; Maranho, L. A.; Pereira, C. D. S. Review on the Occurrence and Biological Effects of Illicit Drugs in Aquatic Ecosystems. Environ Sci Pollut Res 2020, 27 (25), 30998–31034. https://doi.org/10.1007/s11356-020-08375-2.
- Bisceglia, K. J.; Kroening, G.; Subedi, B. GC-MS Methods for Monitoring Illicit Drug Biomarkers in Wastewater: A Critical Review. In ACS Symposium Series; Subedi, B., Burgard, D. A., Loganathan, B. G., Eds.; American Chemical Society: Washington, DC, 2019; Vol. 1319, pp 51–77. https://doi.org/10.1021/bk-2019-1319.ch003.
- Lin, D.-L.; Wang, S.-M.; Wu, C.-H.; Chen, B.-G.; Liu, R. H. Chemical Derivatization for the Analysis of Drugs by GC-MS - A Conceptual Review. Journal of Food and Drug Analysis 2020, 16 (1). https://doi.org/10.38212/2224-6614.2373.
- Scanferla, D. T. P.; Sano Lini, R.; Marchioni, C.; Mossini, S. A. G. Drugs of Abuse: A Narrative Review of Recent Trends in Biological Sample Preparation and Chromatographic Techniques. Forensic Chemistry 2022, 30, 100442. https://doi.org/10.1016/j.forc.2022.100442.
- Daniel R. Knapp. Handbook of Analytical Derivatization Reactions; John Wiley & Sons, 1979.